Athelas (Drug Delivery) Overview
- Year Founded
-
2002
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Investors
-
1
Athelas (Drug Delivery) General Information
Description
Operator of an antibacterial target technology development firm intended for the identification of molecules that prevent bacteria from becoming harmful. The company's technology uses amoebae to measure the virulence of bacteria and allows scientists to systematically screen bacteria for their damaging potential. and can then move on to test the bacteria's reaction to chemical compounds, raising the possibility that they will be able to identify new classes of mechanistic agents to fight infectious diseases.
Contact Information
Corporate Office
- 18, Chemin Des Aulx
- 1228 Plan-les-Ouates
- Switzerland
Corporate Office
- 18, Chemin Des Aulx
- 1228 Plan-les-Ouates
- Switzerland
Athelas (Drug Delivery) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 21-Aug-2006 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 02-Dec-2002 | Completed | Startup | |||
| 1. University Spin-Out | 01-Jan-2002 | Completed | Startup |
Athelas (Drug Delivery) Former Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aravis | Growth/Expansion | Minority | ||
| Angel (individual) | Minority | |||
| Novartis Venture Fund | Corporate Venture Capital | Minority | ||
| Vi Partners | Venture Capital | Minority |
Athelas (Drug Delivery) FAQs
-
When was Athelas (Drug Delivery) founded?
Athelas (Drug Delivery) was founded in 2002.
-
Where is Athelas (Drug Delivery) headquartered?
Athelas (Drug Delivery) is headquartered in Plan-les-Ouates, Switzerland.
-
What industry is Athelas (Drug Delivery) in?
Athelas (Drug Delivery)’s primary industry is Drug Discovery.
-
Is Athelas (Drug Delivery) a private or public company?
Athelas (Drug Delivery) is a Private company.
-
What is Athelas (Drug Delivery)’s current revenue?
The current revenue for Athelas (Drug Delivery) is .
-
How much funding has Athelas (Drug Delivery) raised over time?
Athelas (Drug Delivery) has raised $1.4M.
-
Who are Athelas (Drug Delivery)’s investors?
Aravis, , Novartis Venture Fund, and Vi Partners have invested in Athelas (Drug Delivery).
-
When was Athelas (Drug Delivery) acquired?
Athelas (Drug Delivery) was acquired on 21-Aug-2006.
-
Who acquired Athelas (Drug Delivery)?
Athelas (Drug Delivery) was acquired by MerLion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process